MÖLNDAL, Sweden--(BUSINESS WIRE)--Regulatory News:
Arcam (STO:ARCM), listed on NASDAQ OMX, has received an order for an EBM system from an institute in Japan. The system will be used for implants research.
“This is the eight order from Asia this year. Asia now represents some 30% of our order intake, a significant increase from previous years”, says Magnus René, CEO of Arcam.
The above information has been made public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published on December 3, 2013.
Arcam provides a cost-efficient Additive Manufacturing solution for production of metal components. The technology offers freedom in design combined with excellent material properties and high productivity. Arcam’s market is global with customers mainly in the orthopedic and aerospace industries. The company was founded in 1997 and is listed on NASDAQ OMX Stockholm, Sweden. Head office and production facilities are located in Mölndal, Sweden. Support offices are located in the US, UK, Italy and China.
Arcam AB • Krokslätts Fabriker 27A • SE-431 37 Mölndal, Sweden • 46-31-710 32 00 • www.arcam.com
This information was brought to you by Cision http://news.cision.com